| Old Articles: <Older 26661-26670 Newer> |
|---|
 |
The Motley Fool
October 16, 2007
Alyce Lomax |
AOL Makes the Cuts Following news that it would move many of its America Online executives from Virginia to New York City, Time Warner now announces it's cutting 20% of the AOL workforce.   |
The Motley Fool
October 16, 2007
Brian Orelli |
Pozen Hedges Its Bets As promised, Pozen and partner GlaxoSmithKline announce that the pair have submitted a response to their approvable letter for Trexima, and that they plan to do an additional just-in-case safety trial. |
The Motley Fool
October 16, 2007
Rich Smith |
Foolish Forecast: A Trend at Textron? In advance of third-quarter earnings, analysts expect defense contractor Textron to remain profitable. |
The Motley Fool
October 16, 2007
Matt Koppenheffer |
Citi's Chuck Gets a Gut Check After a disappointing quarter, investors wonder if Citibank is searching for a new CEO. |
The Motley Fool
October 16, 2007
Brian Lawler |
Questions Surround a Biogen Deal Rumors swirl around Biogen after it publicly announces that it's for sale. Investors, take note. |
The Motley Fool
October 16, 2007
Jim Fink |
The Investing Secrets of the Richest Man the World Has Ever Known In inflation-adjusted terms, John D. Rockefeller's early-20th-century fortune is estimated by Forbes to be more than $300 billion. What were his investing secrets? |
The Motley Fool
October 16, 2007
Kristin Graham |
New Oriental Makes the Honor Roll China's private education leader soared past analyst estimates this quarter, with revenue increasing 50.2% and profits rising 63%. |
The Motley Fool
October 16, 2007
Rich Smith |
Foolish Forecast: Labor Ready to Report In advance of earnings reports, analysts expect blue-collar temp agency Labor Ready to turn in another consensus-beating quarter. |
The Motley Fool
October 16, 2007
Rich Smith |
Foolish Forecast: Logitech Lags Locally In advance of earnings reports, analysts would like the Swiss computer peripheral maker Logitech to post sales increase of 11%. |
The Motley Fool
October 16, 2007
Brian Orelli |
Not a Blockbuster -- Yet Merck gains marketing approval for its newest HIV drug. Investors, take note. |
| <Older 26661-26670 Newer> Return to current articles. |
